Acceleration of the Onset of Collagen-Induced Arthritis by a Deficiency of Platelet Endothelial Cell Adhesion Molecule 1

Arthritis and Rheumatism

Volumn 48, Issue 11, 2003, Pages 3280-3290

  Tada, Yoshifumi ^a   Koarada, Syuichi ^a   Morito, Fumitaka ^a   Ushiyama, Osamu ^a   Haruta, Yoshio ^a   Kanegae, Futoshi ^a   Ohta, Akihide ^a   Ho, Alexandra ^b   Mak, Tak W ^b   Nagasawa, Kohei ^a  

^a SAGA UNIVERSITY   (Japan)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; COLLAGEN; COLLAGEN TYPE 2; DYE; GAMMA INTERFERON; IMMUNOGLOBULIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTHRITIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; INTERFERON PRODUCTION; LEUKOCYTE; LEUKOCYTE MIGRATION; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; THROMBOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD31; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; CELL MOVEMENT; COLLAGEN TYPE II; DISEASE MODELS, ANIMAL; HINDLIMB; IMMUNOGLOBULIN G; INTERFERON TYPE II; JOINTS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; SPLEEN; T-LYMPHOCYTES;

EID: 0242579458     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11268     Document Type: Article

References (50)

1. Ohto H, Maeda H, Shibata Y, Chen RF, Ozaki Y, Higashihara M, et al. A novel leukocyte differentiation antigen: two monoclonal antibodies TM2 and TM3 define a 120-kd molecule present on neutrophils, monocytes, platelets, and activated lymphoblasts. Blood 1985;66:873-81.
2. Stockinger H, Gadd SJ, Eher R, Majdic O, Schreiber W, Kasinrerk W, et al. Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol 1990;145:3889-97.
3. Albelda SM, Muller WM, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (endoCAM/CD31); a novel vascular cell-cell adhesion molecule. J Cell Biol 1991;114:1059-68.
4. Newman PJ, Berndt MC, Gorski J, White GC II, Lyman S, Paddock C, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990;247:1219-22.
5. Xie Y, Muller W. Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1. Proc Natl Acad Sci U S A 1993;90:5569-73.
6. Fawcett J, Buckley C, Holness CL, Bird IN, Spragg JH, Saunders J, et al. Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts. J Cell Biol 1995;128:1229-41.
7. Piali L, Hammel P, Uherek C, Bachmann F, Gisler RH, Dunon D, et al. CD31/PECAM-1 is a ligand for αvβ3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 1995;130:451-60.
8. Buckley CD, Doyonnas R, Newton JP, Blystone SD, Brown EJ, Watt SM, et al. Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sci 1996;109:437-45.
9. Deaglio S, Morra M, Mallone R, Ausiello CM, Prager E, Garbarino G, et al. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol 1998;160:395-402.
10. Bogen S, Pak J, Garifallou M, Deng X, Muller WA. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med 1994;179:1059-64.
11. Vaporciyan AA, Delisser HM, Yan H-C, Mendiguren II, Thom SR, Jones ML, et al. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 1993;262:1580-2.
12. Liao F, Huynh HK, Eiroa A, Greene T, Polizzi E, Muller WA. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PE-CAM-1. J Exp Med 1995;182:1337-43.
13. Wakelin MW, Sanz M-J, Dewar A, Albelda SM, Larkin SW, Boughton-Smith N, et al. An anti-platelet/endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through basement membrane. J Exp Med 1996;184:229-39.
14. Christofidou-Solomidou M, Nakada MT, Williams J, Muller WA, DeLisser HM. Neutrophil platelet endothelial cell adhesion molecule-1 participates in neutrophil recruitment at inflammatory sites and is down-regulated after leukocyte extravasation. J Immunol 1997;158:4872-8.
15. Liao F, Ali J, Greene T, Muller WA. Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med 1997;185:1349-57.
16. Liao F, Schenkel AR, Muller WA. Transgenic mice expressing different levels of soluble platelet/endothelial cell adhesion molecule-IgG display distinct inflammatory phenotypes. J Immunol 1999;163:5640-8.
17. Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H, Spellberg J, et al. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1 independent functions. J Immunol 1999;162:3022-30.
18. Thompson RD, Noble KE, Larbi KY, Dewar A, Duncan GS, Mak TW, et al. Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane. Blood 2001;97:1854-60.
19. Newton-Nash DK, Newman PJ. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol 1999;163:682-8.
20. Henshall TL, Jones KL, Wilkinson R, Jackson DE. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling. J Immunol 2001;166:3098-106.
21. Patil S, Newman DK, Newman PJ. Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood 2001;97:1727-32.
22. Sagawa L. Kimura T, Swieter M, Siraganian RP. The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31). J Biol Chem 1997;272:31086-91.
23. Jackson DE, Kupcho KR, Newman PJ. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase SHP-2. J Biol Chem 1997;272:24868-75.
24. Masuda M, Osawa M, Shigematsu H, Harada N, Fujiwara K. Platelet endothelial cell adhesion molecule-1 is a major SH-PTP2 binding protein in vascular endothelial cells. FEBS Lett 1997;408:331-6.
25. Jackson DE, Ward CM, Wang R, Newman PJ. The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation: evidence for a mechanistic link between PECAM-1- and integrin-mediated cellular signaling. J Biol Chem 1997;272:6986-93.
26. Hua CT, Gamble JR, Vadas MA, Jackson DE. Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). J Biol Chem 1998;273:28332-40.
27. Pumphrey NJ, Taylor V, Freeman S, Douglas MR, Bradfield PF, Young SP, et al. Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-γ1 with PECAM-1/CD31. FEBS Lett 1999;450:77-83.
28. Newman DJ, Hamilton C, Newman PJ. Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p561ck. Blood 2001;97:2351-7.
29. Newman PJ. Switched at birth: a new family for PECAM-1. J Clin Invest 1999;193:5-9.
30. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000;290:84-9.
31. Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999;11:141-51.
32. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV. Augmented humoral and anaphylactic response in FcγRII-deficient mice. Nature 1996;379:346-9.
33. Tada Y, Ho A, Koh D-R, Mak TW. Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol 1996;156:4520-6.
34. Brackertz D, Mitchell GF, Mackay IR. Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum 1977;20:841-50.
35. Tada Y, Nagasawa K, Ho A, Morito F, Ushiyama O, Suzuki N, et al. CD28-deficient mice are highly resistant to collagen-induced arthritis. J Immunol 1999;162:203-8.
36. Ashman LK, Aylett GW. Expression of CD31 epitopes on human lymphocytes: CD31 monoclonal antibodies differentiate between naive (CD45RA+) and memory (CD45RA-) CD4-positive T cells. Tissue Antigens 1991;38:208-12.
37. Torimoto Y, Rothstein DM, Dan NH, Schlossman SF, Morimoto C. CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation. J Immunol 1992;148:388-96.
38. Tanaka Y, Albelda SM, Horgan KJ, van Seventer GA, Shimizu Y, Newman W, et al. CD31 expressed on distinctive T cell subsets is a preferential amplifier β1 integrin-mediated adhesion. J Exp Med 1992;176:245-53.
39. Varon D. Platelet/endothelial cell adhesion molecule-1 serves as a co-stimulatory agonist receptor that modulates integrin-dependent adhesion and aggregation of human platelets. Blood 1998;91:500-7.
40. Sagawa K, Swaim W, Zhang J, Unsworth E, Siraganian RP. Aggregation of the high affinity IgE receptor results in the tyrosine phosphorylation of the surface adhesion protein PECAM-1 (CD31). J Biol Chem 1997;272:13412-8.
41. Elias CG III, Spellberg JP, Karan-Tamir B, Lin C-H, Wang Y-J, McKenna PJ, et al. Ligation of CD31/PECAM-1 modulates the function of lymphocytes, monocytes and neutrophils. Eur J Immunol 1998;28:1948-58.
42. Prager E, Sunder-Plassmann R, Hansmann C, Koch C, Holter W, Knapp W, et al. Interaction of CD31 with a heterophilic counter-receptor involved in downregulation of human T cell responses. J Exp Med 1996;184:41-50.
43. Prager E, Staffler G, Majdic O, Säemann MD, Godár S, Zlabinger GJ, et al. Induction of hyporesponsiveness and impaired T lymphocyte activation by the CD31 receptor:ligand pathway in T cells. J Immunol 2001;166:2364-71.
44. Decking J, Mayer A, Petrow P, Seiffge D, Karbowski A. Antibodies to PECAM-1 and glucocorticoids reduce leukocyte adhesion in adjuvant arthritis of the rat knee synovium in vivo. Inflamm Res 2001;50:609-15.
45. Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, Davis S, et al. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest 2002;109:383-92.
46. Johnson BA, Haines GK, Harlow LA, Koch AE. Adhesion molecule expression in human synovial tissue. Arthritis Rheum 1993;36:137-46.
47. Szekanecz Z, Haines GK, Harlow LA, Shah MR, Fong TW, Fu R, et al. Increased synovial expression of the adhesion molecules CD66a, CD66b, and CD31 in rheumatoid and osteoarthritis. Clin Immunol Immunopathol 1995;76:180-6.
48. Tak PP, Thurkow EW, Daha MR, Kluin PM, Smeets TJM, Meinders AE, et al. Expression of adhesion molecules in early rheumatoid synovial tissue. Clin Immunol Immunopathol 1995;77:236-42.
49. To SST, Newman PM, Hyland VJ, Robinson BG, Schrieber L. Regulation of adhesion molecule expression by human synovial microvascular endothelial cells in vitro. Arthritis Rheum 1996;39:467-77.
50. Smith MD, Slavotinek J, Au V, Weedon H, Parker A, Coleman M, et al. Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression. Rheumatology (Oxford) 2001;40:965-77.